Winds of change in Sun Pharma’s $11.75 billion Organon acquisition announcement & more related News Here
Sun Pharmaceutical Industries on Monday announced the $11.75 billion acquisition of Organon & Co, an aggressive move into the US market, which has long decided the global fortunes of Indian drugmakers. However, the biggest purchase by an Indian company in nearly 20 years also signals that the decades-long allure of the US generics market is…